|
π
|
Combined Allogeneic Tumor Cell Vaccination and Systemic Interleukin 12 Prevents Mammary Carcinogenesis in HER-2/neu Transgenic Mice
14 auth.
P. Nanni,
G. Nicoletti,
C. De Giovanni,
L. Landuzzi,
E. Di Carlo,
F. Cavallo,
S. Pupa,
I. Rossi,
M. Colombo,
C. Ricci,
...
A. Astolfi,
P. Musiani,
G. Forni,
P. Lollini
|
8 |
2001 |
8
π
|
|
π
|
p185neu protein is required for tumor and anchorageβindependent growth, not for cell proliferation of transgenic mammary carcinoma
15 auth.
P. Nanni,
S. Pupa,
G. Nicoletti,
C. De Giovanni,
L. Landuzzi,
I. Rossi,
A. Astolfi,
C. Ricci,
Roberta De Vecchi,
A. Invernizzi,
...
E. Di Carlo,
P. Musiani,
G. Forni,
S. MeΜnard,
P. Lollini
|
6 |
2000 |
6
π
|
|
π
|
The metastatic ability of Ewing's sarcoma cells is modulated by stem cell factor and by its receptor c-kit.
12 auth.
L. Landuzzi,
C. Giovanni,
G. Nicoletti,
I. Rossi,
C. Ricci,
A. Astolfi,
...
L. Scopece,
K. Scotlandi,
M. Serra,
G. Bagnara,
P. Nanni,
P. Lollini
|
6 |
2000 |
6
π
|
|
π¦
|
Expression of HER/erbb family of receptor tyrosine kinases and induction of differentiation by glial growth factor 2 in human rhabdomyosarcoma cells
11 auth.
C. Ricci,
L. Landuzzi,
I. Rossi,
C. De Giovanni,
G. Nicoletti,
A. Astolfi,
...
S. Pupa,
S. MeΜnard,
K. Scotlandi,
P. Nanni,
P. Lollini
|
5 |
2000 |
5
π¦
|
|
π¦
|
HER/erbB Receptors as Therapeutic Targets of Immunotoxins in Human Rhabdomyosarcoma Cells
10 auth.
C. Ricci,
L. Polito,
P. Nanni,
L. Landuzzi,
A. Astolfi,
G. Nicoletti,
...
I. Rossi,
C. De Giovanni,
A. Bolognesi,
P. Lollini
|
5 |
2002 |
5
π¦
|
|
π
|
Prevention of HERβ2/neu transgenic mammary carcinoma by tamoxifen plus interleukin 12
13 auth.
P. Nanni,
G. Nicoletti,
C. De Giovanni,
L. Landuzzi,
E. Di Carlo,
M. Iezzi,
C. Ricci,
A. Astolfi,
S. Croci,
F. Marangoni,
...
P. Musiani,
G. Forni,
P. Lollini
|
4 |
2003 |
4
π
|
|
π¬
|
Correlation of natural killer cell function with Leu 7 reactivity in patients with humoral immunodeficiency.
T. Huwyler,
A. Morell,
A. Hirt,
C. Ricci,
H. Wagner,
S. Barandun
|
4 |
1984 |
4
π¬
|
|
π’
|
The human thymus in ageing: histologic involution paralleled by increased mitogen response and by enrichment of OKT3+ lymphocytes.
C. Baroni,
M. Valtieri,
A. Stoppacciaro,
L. Ruco,
S. Uccini,
C. Ricci
|
3 |
1983 |
3
π’
|
|
π
|
Therapy of lung metastases through combined vaccination with carcinoma cells engineered to release IL-13 and IFN-Ξ³
12 auth.
C. Giovanni,
G. Nicoletti,
L. Landuzzi,
I. Rossi,
A. Astolfi,
C. Ricci,
...
E. Carlo,
P. Musiani,
G. Forni,
D. Fradelizi,
P. Nanni,
P. Lollini
|
2 |
2001 |
2
π
|
